RRM2 and non-small cell lung carcinoma: Studies have shown that miR-20a-5p inhibits tumorous angiogenic activity in NSCLC via the RRM2-mediation PI3K/Akt signal path, which may be an effective molecular target for the treatment of NSCLC [93].